Demographic and Clinical Characteristics of Patients Treated With Lecanemab Stratified by Amyloid-Related Imaging Abnormality Status
Saurabh Rohatgi, Christina M Younan, Rafael E Martinez Imbett, Jeremy N Ford, Matthew Wleklinski, Shenghua Zhu, Javier Romero · 2026
Read Demographic and Clinical Characteristics of Patients Treated With Lecanemab Stratified by Amyloid-Related Imaging Abnormality Status by Saurabh Rohatgi, Christina M Younan, Rafael E Martinez Imbett, Jeremy N Ford, Matthew Wleklinski, Shenghua Zhu, Javier Romero (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13570582.txt.
Description
BackgroundAmyloid-related imaging abnormalities (ARIAs) are among the most important safety considerations during lecanemab treatment for Alzheimer’s disease (AD). Although APOE ε4 carrier status is a recognized ARIA risk factor, the relationship between ARIAs and routine demographic and clinical characteristics in real-world practice remains incompletely characterized.
Catalog record
| CREATOR | Saurabh Rohatgi, Christina M Younan, Rafael E Martinez Imbett, Jeremy N Ford, Matthew Wleklinski, Shenghua Zhu, Javier Romero |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |